Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis
- 1 March 2018
- journal article
- research article
- Published by Elsevier BV in Infectious Disease Clinics of North America
- Vol. 32 (1), 91-101
- https://doi.org/10.1016/j.idc.2017.10.006
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Adherence to HIV post-exposure prophylaxis in victims of sexual assault: a systematic review and meta-analysisSexually Transmitted Infections, 2012
- Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in CanadaPharmacoepidemiology and Drug Safety, 2011
- Possible transmission of HIV Infection due to human biteAIDS Research and Therapy, 2011
- Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulationAIDS, 2010
- Physicians’ and patients’ adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern FranceAIDS Care, 2008
- Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure Prophylaxis (NPEP) in a Boston Community Health CenterJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Postexposure Prophylaxis for HIV in Children and Adolescents After Sexual Assault: A Prospective Observational Study in an Urban Medical CenterSexually Transmitted Diseases, 2007
- The use of a triple nucleoside‐nucleotide regimen for nonoccupational HIV post‐exposure prophylaxisHIV Medicine, 2005
- Postexposure Treatment of People Exposed to the Human Immunodeficiency Virus through Sexual Contact or Injection-Drug UseThe New England Journal of Medicine, 1997
- Antiretroviral Therapy for HIV Infection in 1996JAMA, 1996